This website uses cookies to enhance the user experience.
P

PX3 DIAGNOSTICS AS998 461 553

Research
Limited company
Slyngveien 6A 0376 OSLO, Norge

PX3 DIAGNOSTICS AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Links

Organization

Chairman of the board
Years since formation
13 years
since Jun 20, 2012
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
30,000
1 share class
Total number of shareholders
1
person

Financials

Total operating income 2024
553,850
NOK
Annual total result 2024
369,423
NOK
Total equity 2024
357,534
NOK
Last update: Jun 19, 2025

Management

Board

NameRoleShares
Contact Person, Chairman
100 %
directly
Alternate Member-

Others

NameRoleShares
A
AIDER AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Contact Person, Chairman
100 %
directly
Last update: Aug 27, 2024

Ownership

Company shareholders

NameShare classTotal number of sharesShare
Ordinary shares
30,000
100 %

Shares owned by the PX3 DIAGNOSTICS AS

NameShare classTotal number of sharesShare
G
GREINDX AS
Ordinary shares
37,553
31.39 %
N
NAALOS HOLDING AS
Ordinary shares
6,585
21.95 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year2024202320222021
Total operating income
553,850
280,000
265,000
70,000
Annual Total Result
369,423
169,815
110,016
-34,105
Total assets
771,877
261,807
236,801
217,261
Total liabilities
414,343
273,696
418,505
508,981
Total equity
357,534
-11,889
-181,704
-291,720

P&L

Year2024202320222021
Total operating income
553,850
280,000
265,000
70,000
Total operating costs
113,366
124,444
154,984
104,105
Operating result
440,484
155,556
110,016
-34,105
Financial income/costs
10,853
14,259
0
0
Profit before tax
451,337
169,815
110,016
-34,105
Total tax & extraordinary income/cost
81,914
0
0
0
Annual Total Result
369,423
169,815
110,016
-34,105

Balance overview

Year2024202320222021
Total fixed assets
31,955
31,955
79,455
173,470
Total current assets
739,922
229,852
157,346
43,791
Total assets
771,877
261,807
236,801
217,261
Short term debt
341,892
31,359
0
508,981
Long term debt
72,451
242,337
418,505
0
Total liabilities
414,343
273,696
418,505
508,981
Contributed capital
30,000
30,000
30,000
30,000
Retained earnings
327,534
-41,889
-211,704
-321,720
Total equity
357,534
-11,889
-181,704
-291,720
Total equity and liabilities
771,877
261,807
236,801
217,261

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology